Raymond James Financial reiterated their underperform rating on shares of Ventas (NYSE:VTR) in a research note published on Monday morning, Marketbeat.com reports.

Several other equities analysts have also recently issued reports on VTR. BidaskClub cut shares of Ventas from a sell rating to a strong sell rating in a research note on Wednesday, August 9th. Zacks Investment Research cut shares of Ventas from a hold rating to a sell rating in a research note on Wednesday, November 29th. UBS decreased their target price on shares of Ventas from $69.00 to $66.00 and set a neutral rating for the company in a research note on Monday, October 2nd. BMO Capital Markets reiterated a sell rating and issued a $63.00 target price on shares of Ventas in a research note on Monday, November 27th. Finally, SunTrust Banks set a $67.00 target price on shares of Ventas and gave the company a hold rating in a research note on Sunday, October 29th. Eight analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and an average target price of $64.44.

Shares of Ventas (NYSE VTR) opened at $62.99 on Monday. The company has a market cap of $22,374.21, a price-to-earnings ratio of 15.06, a PEG ratio of 4.05 and a beta of 0.08. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 1.06. Ventas has a twelve month low of $58.96 and a twelve month high of $72.36.

Ventas (NYSE:VTR) last posted its earnings results on Friday, October 27th. The real estate investment trust reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.04 by ($0.60). Ventas had a net margin of 32.96% and a return on equity of 6.34%. The firm had revenue of $899.90 million during the quarter, compared to analyst estimates of $893.18 million. During the same quarter in the prior year, the firm earned $1.03 earnings per share. The business’s revenue for the quarter was up 3.8% on a year-over-year basis. sell-side analysts predict that Ventas will post 4.16 earnings per share for the current fiscal year.

A number of large investors have recently bought and sold shares of VTR. Amica Retiree Medical Trust acquired a new position in Ventas during the third quarter worth $131,000. Bronfman E.L. Rothschild L.P. raised its position in Ventas by 48.0% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 2,003 shares of the real estate investment trust’s stock worth $139,000 after acquiring an additional 650 shares during the period. Cable Hill Partners LLC acquired a new position in Ventas during the third quarter worth $174,000. Northern Capital Management LLC acquired a new position in Ventas during the second quarter worth $202,000. Finally, Carnick & Kubik Group LLC acquired a new position in Ventas during the third quarter worth $204,000. Institutional investors own 90.39% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/07/raymond-james-financial-reaffirms-underperform-rating-for-ventas-vtr.html.

About Ventas

Ventas, Inc is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses.

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas Inc. and related companies with MarketBeat.com's FREE daily email newsletter.